ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2018, Vol. 27 ›› Issue (5): 430-434.DOI: 10.3969/j.issn.1006-298X.2018.05.006

• 论文 • 上一篇    下一篇

心脏死亡器官捐献供肾术前病理改变对肾移植预后的影响

  

  • 出版日期:2018-10-28 发布日期:2018-11-14

Effects of pathological  lesions in implantation biopsy on the prognosis of renal grafts from cardiac death donors

  • Online:2018-10-28 Published:2018-11-14

摘要:

目的:应用Pirani评分系统评估心脏死亡后器官捐献(DCD)供肾的组织病变程度,追踪不同程度病变的供肾对肾移植患者短期预后的影响。
方法:(1)研究对象于20150201~20170201在郑州人民医院行DCD供肾移植患者,供肾获取后移植术前行活检病理,即经快速切片后行苏木素伊红(HE)染色,采用Pirani评分系统评估供肾组织病变程度。(2)根据供肾Pirani病理评分分为两组,低分组(0~3分),高分组(4~6分)。(3)观察指标:比较两组肾移植患者的预后,包括移植肾功能延迟恢复(DGF)、术后1月、12月和24月血清肌酐(SCr)及12~36月累计移植肾存活率。
结果:供肾及相应受者共92例纳入本研究,低分组68例(739%),高分组24例(261%)。受体总体DGF发生率为152%,高分组与低分组DGF发生率分别为375%(9/24)和70%(5/68)(P=0028)。受者术后1月、12月、24月低分组SCr值分别为(1049±168)μmol/L、(949±167)μmol/L、(918±93)μmol/L,高分组分别为(1162±344)μmol/L、(1165±149)μmol/L、(1117±102)μmol/L。低分组SCr两年内各个时间点SCr值均低于高分组(P=0041,P=0044,P=0038,P<005)。随访12~36个月,Kaplanmeier分析结果表明高分组与低分组移植肾存活率无明显差异(logRank检验,p=0499)。
结论:DCD供肾病理Pirani评分越高,受者肾移植术后DGF发生率越高,短期移植肾功能越差,但短期内存活率无明显差异。

关键词: 肾移植, 移植病理, 心脏死亡器官捐献供肾

Abstract:

Objective:Using the Pirani scoring system to assess the extent of pathological lesion and to explore the effects of lesions in implantation biopsy on the prognosis of renal grafts from donors after cardiac death(DCD).
Methodology:The kidney donated by DCD in Peoples hospital of Zhengzhou between February 1,2015 to February 1,2017 were  retrospectively reviewed.They were stained with hematoxylineosin (HE) after rapid frozen  and assessed by Pirani scoring system.The pathological results of donor kidney were graded by Pirani pathological score,low score group (0~3 points),high score group (4~6 points). Observation indicators: The prognosis of two groups of renal transplantation patients was compared,such as delayed graft recovery (DGF),postoperative 1st month,12th month,24th month of renal allograft creatinine,and 12~36 months after followup cumulative graft survival rate.
Results:A total of 92 donors and recipients were enrolled in the study. There were 68 patients with low scores(739%,68/92) and 24 patients with high scores(261%,24/92).The overall incidence of DGF was 152%. The incidence of DGF in low group and in high group was 70%(5/68)and 375%(9/24),respectively(P=0028).The mean serum creatinine(SCr) levels at 1st month,12th month,24th month after operation were 1049±168 μmol/L,949±167 μmol/L,and 918±93 μmol/L in low group,and 1162±344 μmol/L,1165±149 μmol/L and 1117±102 μmol/L in high group,respectively.The mean SCr levels in patients at different time points within two years after posttransplantation in low score group were lower than those in high score group (P=0041,P=0044,P=0038,P<005 respectively).After 12~36 months of followup,Kaplanmeier analysis showed no significant difference in survival rate between high and low groups.
Conclusion:The higher the Pirani score of renal pathology,the higher the incidence of DGF after renal transplantation,the shortterm renal allograft function was worse,but there was no significant difference in shortterm survival rate (2 years).

 

Key words: kidney transplantation, implantation biopsy, cardiac death donor